Three-dimensional structure of a Nanobody® (modeled on the VHH with pdb-code 1U0Q, Cambillau et al). The target molecule is recognized by the surface formed by three hypervariable regions located at the top of the molecule (in green, cyan and blue). Hallmarks, amino acid residues that further differentiate a camelid VHH from a human VH, can be located at different positions within the framework regions, and here are coloured red, pink and magenta.

Home INVESTOR RELATIONS Contact us

Contact Us

Finance & Investor Relations

To obtain information about Ablynx and its activities, please contact the Finance and Investor Relations Department.

Note : only investor relations-related requests will be handled.

Wim Ottevaere

Chief Financial Officer

Ablynx nv

Technologiepark 4

B-9052 Zwijnaarde/Ghent

T : + 32 (0)9 262 00 00

F : + 32 (0)9 262 00 02

wim.ottevaere@ablynx.com

 

Corporate Communication

To obtain information about Ablynx, please contact the Corporate Communication Department.

Eva-Lotta Allan

Chief Business Officer

Ablynx nv

Technologiepark 4

B-9052 Zwijnaarde/Ghent

T : + 32 (0)9 262 00 00

F : + 32 (0)9 262 00 02

eva-lotta.allan@ablynx.com


Latest News


27/07/2010

ABLYNX ANNOUNCES CHANGE IN MANAGEMENT

23/07/2010

ABLYNX ANNOUNCES WARRANT EXERCISE

12/07/2010

NOVARTIS OBTAINS LICENSES TO DEVELOP AND COMMERCIALISE TWO NOVEL NANOBODIES®


Email alerts

If you would like to receive updates on the company news, please
click here